香蕉视频

Home / News

Researchers identify gene associated with intracranial aneurysm in French-Canadian population

Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.

Using genetic analysis, the team of researchers found rare variations of one gene, RNF213, that appeared more frequently in IA patients than in the control group. Both patients and the control group came from French-Canadian families.

Classified as: Guy Rouleau, Simon Girard, intracranial aneurysm, moya moya disease, IA, RNF213
Category:
Published on: 31 Oct 2016

A Brilliant Success

A Brilliant Night raises $1 million for brain cancer research

A Brilliant Night raised an astounding $1 million for brain cancer research at its gala event on Oct. 19.

Classified as: a brilliant night, brain cancer, brain tumor, Kevin Petrecca, medicine research
Category:
Published on: 27 Oct 2016

Essential tremor sufferers needed for groundbreaking study

You probably know someone who has it. It is the most common movement disorder, yet most people don鈥檛 even know its name.

Essential tremor affects nearly one per cent of the world鈥檚 population, increasing to four per cent of those over 40. The involuntary shaking of hands is the most common symptom, but symptoms can also include shaking of the head and legs.

Classified as: genetics, Guy Rouleau, essential tremor, Simon Girard, movement disorders
Category:
Published on: 21 Oct 2016

The Neuro names Susan Cameron Cook Neuro-Palliative Care Program

The Montreal Neurological Institute and Hospital (The Neuro) is pleased to announce a new initiative designed to ease the suffering of seriously ill patients through specialized consultation and comprehensive care.

The Susan Cameron Cook Neuro-Palliative Care Program, named in honour of Susan Cameron Cook, whose family provided vital seed funding for this initiative, has the goal of reducing the mental and physical suffering of neurological patients and their families in the journey from diagnosis of a terminal illness to end of life.

Classified as: Palliative Care, terminal illness, Cook family, Neuro-Palliative Care, Guy Rouleau
Category:
Published on: 17 Oct 2016

Dr. Guy Rouleau receives national award for significant contributions to world of science

Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital at 香蕉视频 and the 香蕉视频 Health Centre, has been chosen to receive another major award recognizing his outstanding scientific career. The national organization representing Canadian francophone doctors, M茅decins francophones du Canada, is bestowing on him its 2016 Prix de l鈥檕euvre scientifique.

Classified as: Guy Rouleau, Prix de l鈥檕euvre scientifique, M茅decins francophones du Canada
Category:
Published on: 13 Oct 2016

A Brilliant Night 2016

Inspiring event to raise money for brain cancer research

An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.

Classified as: Kevin Petrecca, Fundraising, brain cancer, brain tumor, a brilliant night
Category:
Published on: 4 Oct 2016

KalGene gears up to manufacture and test promising 础濒锄丑别颈尘别谤鈥檚 treatment with NRC, McGill and CIMTEC

KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel 础濒锄丑别颈尘别谤鈥檚 treatment in Canada that the parties have been co- developing since 2015.

The treatment, a biologic molecule made up of a peptide that fights 础濒锄丑别颈尘别谤鈥檚 and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.

Classified as: Montreal Neurological Institute, 础濒锄丑别颈尘别谤鈥檚, National Research Council of Canada, NRC, KalGene, Rosa-Neto, ranslational Neuroimaging, CIMTEC, Douglas Research Institute
Category:
Published on: 3 Oct 2016

Team led by MNI researcher receive $6.1 million to study MS

A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.

The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.

Classified as: Multiple Sclerosis, MS, Progressive MS, Douglas Arnold
Category:
Published on: 20 Sep 2016

Dr. Guy Rouleau elected to Royal Society of Canada

The Neuro鈥檚 director, Dr. Guy Rouleau, has received yet another honour in recognition of his sterling scientific career. The Royal Society of Canada (RSC) that its members had elected Dr. Rouleau as one of its new Fellows. He joins a currently active membership of more than 2,000 highly distinguished scientists, scholars and artists who nominate and elect up to 75 new members each year.

Classified as: Guy Rouleau, royal society of canada, rsc
Category:
Published on: 8 Sep 2016

Continuing the fight against brain cancer

Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman

听

With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.

Classified as: brain cancer, brain tumor, a brilliant night, Fundraiser, Kevin Petrecca
Category:
Published on: 31 Aug 2016

Researchers find new role for cannabinoids in vision

Chemicals shown to improve low-light vision of tadpoles by sensitizing retinal cells

A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.

Classified as: vision, Ruthazer, cannabinoids, retina
Category:
Published on: 25 Aug 2016

Dr. Boris Bernhardt joins the BIC as new Principal Investigator

We are fortunate to welcome Dr.听Boris Bernhardt as BIC core Faculty Member as of August 1, 2016. Boris is a new听Assistant Professor in the Department of Neurology and Neurosurgery at McGill and a member of the Epilepsy research group at the MNI. He obtained his PhD in Neuroscience at McGill in 2011 and carried out postdoctoral studies at the Max-Planck Institute for Cognitive and Brain Sciences in Leipzig, Germany. Boris heads the newly-founded听听at the BIC.

Classified as: BIC
Category:
Published on: 22 Aug 2016

Gaming camera could aid MS treatment

3D depth-sensing camera shown to measure walking difficulties

A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.

The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.

Classified as: MS, Multiple Sclerosis, engineering, Research, daria trojan
Category:
Published on: 15 Aug 2016

鈥淏ig Data鈥� study discovers earliest sign of 础濒锄丑别颈尘别谤鈥檚 development

Research underlines importance of computational power in future neurological breakthrough

Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset 础濒锄丑别颈尘别谤鈥檚 disease (LOAD), identifying its first physiological signs.

Classified as: 础濒锄丑别颈尘别谤鈥檚, 础濒锄丑别颈尘别谤鈥檚 disease, Alan Evans, big data, physiology, ADNI, Yasser Iturria Medina
Category:
Published on: 11 Jul 2016

Researchers open new path of discovery in Parkinson鈥檚 disease

A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at 香蕉视频 have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.

Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.

Classified as: Parkinson's disease, Parkinson's, mitochondria, autoimmune disease, genetics, PINK1, Parkin, Heidi McBride
Category:
Published on: 27 Jun 2016

Pages

Back to top